BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12745451)

  • 1. Concurrent responses elicited by isolated activation of platelet Gq-coupled receptors, in vitro: a novel approach for their separation and analysis.
    Maayani S; Patel ND; Craddock-Royal BD; Schwarz TE; Tagliente TM
    Platelets; 2003 Mar; 14(2):89-102. PubMed ID: 12745451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor; pharmacological and kinetic studies in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003 Sep; 14(6):359-74. PubMed ID: 14602550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deaggregation is an integral component of the response of platelets to ADP in vitro: kinetic studies of literature and original data.
    Maayani S; Tagliente TM; Schwarz T; Craddock-Royal B; Alcala C; Marrero G; Martinez R
    Platelets; 2001 Aug; 12(5):279-91. PubMed ID: 11487380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
    Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
    Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet receptors for adenine nucleotides and thromboxane A2.
    Murugappan S; Shankar H; Kunapuli SP
    Semin Thromb Hemost; 2004 Aug; 30(4):411-8. PubMed ID: 15354262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets?
    Kahner BN; Quinton TM; Langan S; Kunapuli SP
    Platelets; 2006 Sep; 17(6):397-404. PubMed ID: 16973501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
    Dovlatova N; Wijeyeratne YD; Fox SC; Manolopoulos P; Johnson AJ; White AE; Latif ML; Ralevic V; Heptinstall S
    Thromb Haemost; 2008 Aug; 100(2):261-70. PubMed ID: 18690346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    GrĂ¼ner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
    Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin.
    Frelinger AL; Jakubowski JA; Li Y; Barnard MR; Fox ML; Linden MD; Sugidachi A; Winters KJ; Furman MI; Michelson AD
    Thromb Haemost; 2007 Jul; 98(1):192-200. PubMed ID: 17598013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
    Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
    Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
    Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
    Johnson FL; Boyer JL; Leese PT; Crean C; Krishnamoorthy R; Durham T; Fox AW; Kellerman DJ
    Platelets; 2007 Aug; 18(5):346-56. PubMed ID: 17654304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles for P2X1 receptors in platelet activation.
    Mahaut-Smith MP; Tolhurst G; Evans RJ
    Platelets; 2004 May; 15(3):131-44. PubMed ID: 15203715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
    Sim DS; Dilks JR; Flaumenhaft R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
    Judge HM; Buckland RJ; Sugidachi A; Jakubowski JA; Storey RF
    Platelets; 2008 Mar; 19(2):125-33. PubMed ID: 18297550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.